Advertisement

Medical Oncology

, 30:634 | Cite as

Bone metastasis from breast cancer involves elevated IL-11 expression and the gp130/STAT3 pathway

  • Li RenEmail author
  • Xia Wang
  • Zuoliang Dong
  • Jun Liu
  • Shiwu Zhang
Original Paper

Abstract

To evaluate the relationship between IL-11 and bone metastasis in patients with breast cancer and explore the potential molecular mechanism, total serum samples were collected from 180 breast cancer patients and 20 women without breast cancer. The serum expression level of interleukin (IL)-11, connective tissue growth factor (CTGF), transforming growth factor-β, and Tracp5b was determined by enzyme-linked immunosorbent assay, and mRNA expression of IL-11 in fresh breast cancer tissue was determined by RT-PCR. Immunohistochemical staining was used to detect the expression of IL-11 and CTGF in breast cancer tissue, and Western blot was used to detect the expression of p-38, p-C-JUN, p-STAT3, and p-gp130 in fresh breast cancer tissue. DNA-binding activity of AP-1 was examined by electrophoretic mobility shift assay. Differences were statistically analyzed between the group with breast cancer metastatic to bone (MBC-B) and the group with only primary breast cancer (PBC). Serum level and mRNA expression of IL-11 in the MBC-B group were significantly higher than those in the PBC group. IL-11 immunohistochemical staining showed that the percentage of positively stained cells in the MBC-B group (57.5 %) was significantly higher than that in the PBC group (14.29 %). Western blot analysis showed higher expression of p-p38, p-C-JUN, p-STAT3, and p-gp130 in the MBC-B group than in the PBC group. DNA-binding activity of AP-1 was significantly higher in the MBC-B group than in the PBC group. These data suggest that IL-11 is associated with bone metastasis and may be of value for predicting bone metastasis from breast cancer.

Keywords

Breast cancer Bone metastasis Interleukin-11 gp130 STAT3 

Abbreviations

MBC-B

Breast cancer metastatic to bone

PBC

Primary breast cancer

TGF-β

Transforming growth factor-β

CTGF

Connective tissue growth factor

IHC

Immunohistochemical staining

IL

Interleukin

Notes

Acknowledgments

This work was supported by the National Science Foundation of China (81071631), Tianjin Medical University Science Foundation (2010KY36), Key Project of Natural Science Foundation of Anhui Education Department (KJ2010A179). We also thank Dr. Zhuang Cui for his professional statistical suggestions.

Conflict of interest

The authors declare that they have no competing interests.

References

  1. 1.
    Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s–9s.PubMedCrossRefGoogle Scholar
  2. 2.
    Bohn OL, Nasir I, Brufsky A, Tseng GC, Bhargava R, MacManus K, Chivukula M. Biomarker profile in breast carcinomas presenting with bone metastasis. International J Clin Exp Pathol. 2009;3(2):139–46.Google Scholar
  3. 3.
    Roodman GD. Mechanisms of bone metastasis. N Engl J Med. 2004;350(16):1655–64.PubMedCrossRefGoogle Scholar
  4. 4.
    Kominsky SL, Davidson NE. A “bone” fide predictor of metastasis? Predicting breast cancer metastasis to bone. J Clin Oncol. 2006;24(15):2227–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Massague J. TGFbeta in cancer. Cell. 2008;134(2):215–30.PubMedCrossRefGoogle Scholar
  6. 6.
    Girasole G, Passeri G, Jilka RL, Manolagas SC. Interleukin-11: a new cytokine critical for osteoclast development. J Clin Investig. 1994;93(4):1516–24.PubMedCrossRefGoogle Scholar
  7. 7.
    Sotiriou C, Lacroix M, Lespagnard L, Larsimont D, Paesmans M, Body JJ. Interleukins-6 and -11 expression in primary breast cancer and subsequent development of bone metastases. Cancer Lett. 2001;169(1):87–95.PubMedCrossRefGoogle Scholar
  8. 8.
    Zhou YL, Snead ML. Identification of CCAAT/enhancer-binding protein alpha as a transactivator of the mouse amelogenin gene. The J Biol Chem. 2000;275(16):12273–80.CrossRefGoogle Scholar
  9. 9.
    Chu P, Chao TY, Lin YF, Janckila AJ, Yam LT. Correlation between histomorphometric parameters of bone resorption and serum type 5b tartrate-resistant acid phosphatase in uremic patients on maintenance hemodialysis. Am J Kidney Dis. 2003;41(5):1052–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Ehata S, Hanyu A, Fujime M, Katsuno Y, Fukunaga E, Goto K, Ishikawa Y, Nomura K, Yokoo H, Shimizu T, et al. Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line. Cancer Sci. 2007;98(1):127–33.PubMedCrossRefGoogle Scholar
  11. 11.
    Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer. 2002;2(8):584–93.PubMedCrossRefGoogle Scholar
  12. 12.
    Ao M, Franco OE, Park D, Raman D, Williams K, Hayward SW. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res. 2007;67(9):4244–53.PubMedCrossRefGoogle Scholar
  13. 13.
    Kakonen SM, Selander KS, Chirgwin JM, Yin JJ, Burns S, Rankin WA, Grubbs BG, Dallas M, Cui Y, Guise TA. Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. The J Biol Chem. 2002;277(27):24571–8.CrossRefGoogle Scholar
  14. 14.
    Dimitriadis E, Robb L, Liu YX, Enders AC, Martin H, Stoikos C, Wallace E, Salamonsen LA. IL-11 and IL-11Ralpha immunolocalisation at primate implantation sites supports a role for IL-11 in placentation and fetal development. Reprod Biol Endocrinol. 2003;1:34.PubMedCrossRefGoogle Scholar
  15. 15.
    Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3(6):537–49.PubMedCrossRefGoogle Scholar
  16. 16.
    Morgan H, Tumber A, Hill PA. Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor. Int J cancer. 2004;109(5):653–60.PubMedCrossRefGoogle Scholar
  17. 17.
    Sterling JA, Edwards JR, Martin TJ, Mundy GR. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior. Bone. 2011;48(1):6–15.PubMedCrossRefGoogle Scholar
  18. 18.
    Chiang AC, Massague J. Molecular basis of metastasis. N Engl J Med. 2008;359(26):2814–23.PubMedCrossRefGoogle Scholar
  19. 19.
    Lacroix M, Siwek B, Marie PJ, Body JJ. Production and regulation of interleukin-11 by breast cancer cells. Cancer Lett. 1998;127(1–2):29–35.PubMedCrossRefGoogle Scholar
  20. 20.
    Gupta J, Robbins J, Jilling T, Seth P. TGFbeta-dependent induction of interleukin-11 and interleukin-8 involves SMAD and p38 MAPK pathways in breast tumor models with varied bone metastases potential. Cancer Biol Ther. 2011;11(3):311–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Paul SR, Bennett F, Calvetti JA, Kelleher K, Wood CR, O’Hara RM Jr, Leary AC, Sibley B, Clark SC, Williams DA, et al. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA. 1990;87(19):7512–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Yang L, Yang YC. Regulation of interleukin (IL)-11 gene expression in IL-1 induced primate bone marrow stromal cells. J Biol Chem. 1994;269(52):32732–9.PubMedGoogle Scholar
  23. 23.
    Suen Y, Chang M, Lee SM, Buzby JS, Cairo MS. Regulation of interleukin-11 protein and mRNA expression in neonatal and adult fibroblasts and endothelial cells. Blood. 1994;84(12):4125–34.PubMedGoogle Scholar
  24. 24.
    Maier R, Ganu V, Lotz M. Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J Biol Chem. 1993;268(29):21527–32.PubMedGoogle Scholar
  25. 25.
    Elias JA, Zheng T, Whiting NL, Trow TK, Merrill WW, Zitnik R, Ray P, Alderman EM. IL-1 and transforming growth factor-beta regulation of fibroblast-derived IL-11. J Immunol. 1994;152(5):2421–9.PubMedGoogle Scholar
  26. 26.
    Tang W, Yang L, Yang YC, Leng SX, Elias JA. Transforming growth factor-beta stimulates interleukin-11 transcription via complex activating protein-1-dependent pathways. J Biol Chem. 1998;273(10):5506–13.PubMedCrossRefGoogle Scholar
  27. 27.
    Bamba S, Andoh A, Yasui H, Makino J, Kim S, Fujiyama Y. Regulation of IL-11 expression in intestinal myofibroblasts: role of c-Jun AP-1- and MAPK-dependent pathways. Am J Physiol Gastrointest Liver Physiol. 2003;285(3):G529–38.PubMedGoogle Scholar
  28. 28.
    Merchant JL. What lurks beneath: IL-11, via Stat3, promotes inflammation-associated gastric tumorigenesis. J Clin Investig. 2008;118(5):1628–31.PubMedGoogle Scholar
  29. 29.
    Snyder M, Huang XY, Zhang JJ. Signal transducers and activators of transcription 3 (STAT3) directly regulates cytokine-induced fascin expression and is required for breast cancer cell migration. J Biol Chem. 2011;286(45):38886–93.PubMedCrossRefGoogle Scholar
  30. 30.
    Sims NA, Walsh NC. GP130 cytokines and bone remodelling in health and disease. BMB Rep. 2010;43(8):513–23.PubMedCrossRefGoogle Scholar
  31. 31.
    Bishop KA, Meyer MB, Pike JW. A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression. Mol Endocrinol. 2009;23(12):2095–110.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Li Ren
    • 1
    Email author
  • Xia Wang
    • 2
  • Zuoliang Dong
    • 3
  • Jun Liu
    • 4
  • Shiwu Zhang
    • 5
  1. 1.Department of Laboratory, Key Laboratory of Cancer Prevention and TherapyTianjin Medical University Cancer Institute and HospitalTianjinPeople’s Republic of China
  2. 2.Department of Gastrointestinal CancerTianjin Medical University Cancer Institute and HospitalTianjinPeople’s Republic of China
  3. 3.Department of LaboratoryTianjin Medical University General HospitalTianjinPeople’s Republic of China
  4. 4.Department of Medical Imaging, Tianjin Union Medicine CenterNankai University Affiliated HospitalTianjinPeople’s Republic of China
  5. 5.Department of Pathology, Tianjin Union Medicine CenterNankai University Affiliated HospitalTianjinPeople’s Republic of China

Personalised recommendations